AU2001275820A1 - Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same - Google Patents
Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the sameInfo
- Publication number
- AU2001275820A1 AU2001275820A1 AU2001275820A AU7582001A AU2001275820A1 AU 2001275820 A1 AU2001275820 A1 AU 2001275820A1 AU 2001275820 A AU2001275820 A AU 2001275820A AU 7582001 A AU7582001 A AU 7582001A AU 2001275820 A1 AU2001275820 A1 AU 2001275820A1
- Authority
- AU
- Australia
- Prior art keywords
- fetal
- diagnostic
- same
- kit containing
- prenatal diagnosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR0069283 | 2000-11-21 | ||
KR10-2000-0069283A KR100425525B1 (en) | 2000-11-21 | 2000-11-21 | Diagnostic agents for detecting premature birth, fetal infection and fetal damage and diagnostic kit containing the same |
PCT/KR2001/001306 WO2002042770A1 (en) | 2000-11-21 | 2001-08-01 | Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001275820A1 true AU2001275820A1 (en) | 2002-06-03 |
Family
ID=19700313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001275820A Abandoned AU2001275820A1 (en) | 2000-11-21 | 2001-08-01 | Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same |
Country Status (7)
Country | Link |
---|---|
US (1) | US7232661B2 (en) |
EP (1) | EP1336103A4 (en) |
JP (1) | JP4011479B2 (en) |
KR (1) | KR100425525B1 (en) |
CN (1) | CN1245626C (en) |
AU (1) | AU2001275820A1 (en) |
WO (1) | WO2002042770A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2435510A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | Enzyme detection product and methods |
GB2435512A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | A binding assay and assay device |
GB2435511A (en) * | 2006-02-23 | 2007-08-29 | Mologic Ltd | Protease detection |
GB2437311A (en) * | 2006-04-07 | 2007-10-24 | Mologic Ltd | A protease detection product |
EP2083863B1 (en) | 2006-10-03 | 2015-03-18 | Genzyme Corporation | Antibodies to tgf-beta for use in the treatment of infants at risk of developing bronchopulmonary dysplasia |
WO2008137567A1 (en) * | 2007-05-01 | 2008-11-13 | Cedars-Sinai Medical Center | Caspase inhibitors in the treatment of infection-associated preterm delivery |
CN104777307B (en) * | 2008-10-31 | 2019-10-18 | 耶鲁大学 | The method and composition of pre-eclampsia detection and treatment |
EP2510356B1 (en) * | 2009-12-08 | 2018-10-31 | Cedars-Sinai Medical Center | Diagnostic method to identify women at risk for preterm delivery |
WO2012125641A1 (en) | 2011-03-17 | 2012-09-20 | Cedars-Sinai Medical Center | Diagnostic biomarker to predict women at risk for preterm delivery |
CA2912700A1 (en) * | 2013-05-16 | 2014-11-20 | Basetra Medical Technology Co. Ltd. | Fetal diagnostics using fetal cell capture from maternal blood |
CN104498431B (en) * | 2015-01-23 | 2017-10-20 | 温州市中心医院 | A kind of method of slide Culture in situ amniocyte and caryogram Treatment Analysis |
KR101578526B1 (en) * | 2015-07-14 | 2015-12-17 | 이화여자대학교 산학협력단 | Marker il-13 for predicting a risk of early (<32 weeks) preterm delivery and use thereof |
KR101589673B1 (en) * | 2015-10-12 | 2016-01-28 | (주)휴레이포지티브 | infectious disease diagnosis method and apparatus by image of reagent kit |
KR101695347B1 (en) | 2015-10-12 | 2017-01-11 | 이화여자대학교 산학협력단 | Composition for predicting a risk of preterm delivery using CpG methylation status of gene and uses thereof |
EP3370676B1 (en) | 2015-11-06 | 2023-12-13 | Amnion Life, LLC | Premature infant amniotic bath incubator |
CN110100182A (en) * | 2016-12-23 | 2019-08-06 | 苏珊娜·潘格拉茨-菲雷尔 | Effect of the α-B crystallin in diagnosis Neonatal Brain Damage |
WO2018220129A1 (en) | 2017-05-31 | 2018-12-06 | B.R.A.H.M.S Gmbh | Mmp-8 as a marker for identifying infectious disease |
EP3438668A1 (en) | 2017-08-04 | 2019-02-06 | B.R.A.H.M.S GmbH | Diagnosis and risk stratification of fungal infections |
ES2909399T3 (en) | 2017-09-13 | 2022-05-06 | Brahms Gmbh | Proadrenomedullin as a marker of abnormal platelet levels |
RU2687486C1 (en) * | 2018-02-05 | 2019-05-14 | Федеральное государственное бюджетное образовательное учреждение высшего образования Кубанский государственный медицинский университет Министерства Здравоохранения Российской Федерации (ФГБОУ ВО КУбГМУ МЗ РФ) | Method for determining a risk of intrauterine fetus infection in females suffering influenza a(h1n1) in pregnancy |
KR102184911B1 (en) * | 2019-06-07 | 2020-12-01 | 한림대학교 산학협력단 | Preventing or treating composition for preterm birth containing miR-548 |
CN111513729B (en) * | 2020-05-07 | 2021-04-27 | 吉林大学 | Efficient prenatal diagnosis interphase fetal cell detection device |
KR102339013B1 (en) * | 2020-11-16 | 2021-12-14 | 주식회사 옵티바이오 | In-vitro diagnostic kit capable of quantitating mmp-8 in amniotic fluid specimen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5597700A (en) | 1994-04-28 | 1997-01-28 | California Research, Llc | Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method |
FI98961C (en) * | 1994-08-26 | 1997-09-10 | Medix Biochemica Ab Oy | Procedure and test means for diagnosing periodontal disease activity and / or peri-implantitis and / or increased risk thereof |
US5545616A (en) | 1994-09-22 | 1996-08-13 | Genentech, Inc. | Method for predicting and/or preventing preterm labor |
-
2000
- 2000-11-21 KR KR10-2000-0069283A patent/KR100425525B1/en active IP Right Grant
-
2001
- 2001-08-01 CN CNB018192696A patent/CN1245626C/en not_active Expired - Fee Related
- 2001-08-01 WO PCT/KR2001/001306 patent/WO2002042770A1/en active Application Filing
- 2001-08-01 EP EP01953363A patent/EP1336103A4/en not_active Withdrawn
- 2001-08-01 JP JP2002544659A patent/JP4011479B2/en not_active Expired - Fee Related
- 2001-08-01 US US10/415,763 patent/US7232661B2/en not_active Expired - Fee Related
- 2001-08-01 AU AU2001275820A patent/AU2001275820A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1476537A (en) | 2004-02-18 |
US7232661B2 (en) | 2007-06-19 |
EP1336103A4 (en) | 2007-05-09 |
JP2004522942A (en) | 2004-07-29 |
EP1336103A1 (en) | 2003-08-20 |
US20040029176A1 (en) | 2004-02-12 |
WO2002042770A1 (en) | 2002-05-30 |
CN1245626C (en) | 2006-03-15 |
KR20020039458A (en) | 2002-05-27 |
KR100425525B1 (en) | 2004-03-30 |
JP4011479B2 (en) | 2007-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001275820A1 (en) | Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same | |
AU2815900A (en) | Clinical and diagnostic database | |
AU2001248550A1 (en) | Non-invasive prenatal diagnosis using cd45-ve fetal cells | |
AU2001271412A1 (en) | Diagnostic port between independent robots | |
AU2002314224A1 (en) | Prenatal diagnosis method on isolated foetal cell of maternal blood | |
AUPR005600A0 (en) | Diagnostic assay | |
AUPQ886100A0 (en) | Diagnostic test | |
AUPR044000A0 (en) | Diagnostic device | |
AU2002317454A1 (en) | Methods and apparatus for objective fetal diagnosis | |
AU2002327185A1 (en) | Diagnostic methods and devices | |
AU4522201A (en) | Cryopreservation compositions and methods for peripheral blood lymphocytes | |
AU6735600A (en) | Multipurpose diagnostic systems using protein chips | |
AU5070999A (en) | (streptococcus suis) vaccines and diagnostic tests | |
AU2001266910A1 (en) | Secure medical test and result delivery system | |
WO2003084384A3 (en) | Diagnosis of flavivirus infection | |
AU3760400A (en) | Methods and reagents for the diagnosis and treatment of multiple sclerosis | |
IL162095A0 (en) | Formulations for use in medical or diagnostic procedures | |
AU1238501A (en) | Process for consumer-directed diagnostic and health care information | |
AU3697899A (en) | Diagnostic agent for mr diagnosis | |
AU3978700A (en) | Medical use | |
AU1163101A (en) | Diagnostic methods | |
AU6835300A (en) | Diagnostic kit and use thereof | |
AU3460800A (en) | Method of bleaching blood samples, diagnostic method and diagnostic kit using the same | |
AU6200399A (en) | Avian pneumovirus vaccine and diagnostic agent | |
AU2001280732A1 (en) | Pregnancy and sex identification test based on saliva or other bodily fluids |